XDC Network, Bitso Business tie up to support US-Mexico remittances
The XDC Network has joined forces with Bitso Business to establish a blockchain remittance corridor aimed at enhancing payment transactions between the US and Mexico.
The initiative is expected to utilise blockchain technology to facilitate 'near-instant payments'.
This collaboration integrates the XDC Network's ISO 20022-compatible blockchain infrastructure with Bitso Business' fiat conversion services in Latin America.
The remittance corridor is designed to offer a alternative to conventional payment methods in the region.
The partnership aims to offer low cost remittances, with transactions settling in mere seconds at 'minimal' fees, the company said.
It also supports multiple currencies, enabling swift USD to MXN conversions through Bitso's liquidity channels in Latin America.
The service is tailored for SMEs, fintechs, and institutions that require efficient payment solutions for international suppliers or payroll.
Conforming to ISO 20022-compliant messaging standards, the payment rail is compatible with existing banking systems and regulated entities, in line with XDC's objective to enhance adoption in emerging markets.
With over ten years of operational experience, Bitso's APIs and regulatory connections across Latin America expected to add 'interoperability' to the XDC Network.
XDC Network Ecosystem Development Amitava Mandal said: "This partnership with Bitso Business marks a major leap toward our mission of bridging traditional finance with blockchain efficiency. Together, we're delivering faster, fairer cross-border transfers that solve real-world challenges in global remittances and SME trade."
The XDC Network is an EVM-compatible blockchain focused on tokenising real-world assets, digitising trade finance, and providing infrastructure for cross-border settlements.
Bitso Business, meanwhile, offers services including Pay-ins and Payouts in Latin America, Cross-Border payments, as well as Trading and OTC services.
"XDC Network, Bitso Business tie up to support US-Mexico remittances " was originally created and published by Electronic Payments International, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
35 minutes ago
- Yahoo
Pharmaceutical Grade Sodium Chloride Research Business Report 2025-2030 - Growth in Emerging Markets Expands Addressable Opportunities
The pharmaceutical grade sodium chloride market is set to grow from USD 701.9 million in 2024 to USD 973.7 million by 2030, at a CAGR of 5.6%. This growth is driven by increased demand in healthcare applications, such as IV solutions, dialysis, and drug formulations, due to rising chronic disease prevalence and an aging population. Technological advancements in purification and manufacturing, coupled with stringent regulatory standards, enhance product quality. Key regions include the U.S., China, and Europe, with notable growth expected in the Asia-Pacific region. Major players like Akzo Nobel NV and Morton Salt, Inc. are strategically positioned within this expanding market. Pharmaceutical Grade Sodium Chloride Market Dublin, June 09, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Grade Sodium Chloride - Global Strategic Business Report" report has been added to global market for Pharmaceutical Grade Sodium Chloride was valued at US$701.9 Million in 2024 and is projected to reach US$973.7 Million by 2030, growing at a CAGR of 5.6% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. Pharmaceutical grade sodium chloride plays a critical role in various pharmaceutical formulations, including intravenous (IV) saline solutions, oral rehydration salts, and as a diluent for injectable drugs. The purity and consistency of pharmaceutical grade sodium chloride are paramount as they ensure that medications meet stringent regulatory standards and provide effective treatment. Its use extends to dialysis solutions, wound care products, and even as a nasal rinse, highlighting its versatility and indispensability in modern healthcare. What Factors Are Driving Growth in the Pharmaceutical Grade Sodium Chloride Market?The growth in the pharmaceutical grade sodium chloride market is driven by several factors. Firstly, the increasing prevalence of chronic diseases such as diabetes and kidney disorders is boosting the demand for IV saline solutions and dialysis treatments, where high-purity sodium chloride is essential. Technological advancements in purification and manufacturing processes are enhancing product quality and expanding production capacity, meeting the rising healthcare needs. Additionally, the aging global population is contributing to higher demand for various medical treatments that utilize pharmaceutical grade sodium chloride. The expansion of the biopharmaceutical sector, which requires high-quality raw materials for drug formulation and production, is further propelling market growth. Furthermore, stringent regulatory standards are driving manufacturers to continuously improve their production processes and quality controls, ensuring the supply of safe and effective pharmaceutical grade sodium chloride. Lastly, the increasing focus on personalized medicine and advanced drug delivery systems is creating new opportunities for specialized applications of pharmaceutical sodium chloride, fueling market expansion. How Are Technological Advancements Enhancing the Quality of Pharmaceutical Sodium Chloride?Technological advancements have significantly improved the production and quality control of pharmaceutical grade sodium chloride. Advanced purification techniques, such as recrystallization and membrane filtration, have enhanced the removal of impurities, ensuring high-purity sodium chloride that meets the stringent standards of pharmacopeias worldwide. The implementation of sophisticated analytical methods, including high-performance liquid chromatography (HPLC) and atomic absorption spectroscopy (AAS), allows for precise monitoring of impurity levels, ensuring consistency and safety. Furthermore, automation in manufacturing processes has minimized human error and increased production efficiency. These technological strides not only ensure the high quality of pharmaceutical sodium chloride but also enable large-scale production to meet the growing demand in the healthcare Are the Regulatory and Safety Standards Governing Pharmaceutical Sodium Chloride?Pharmaceutical grade sodium chloride is subject to rigorous regulatory and safety standards to ensure its suitability for medical use. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) impose strict guidelines on the production, testing, and labeling of this critical ingredient. Compliance with pharmacopeial standards, such as the United States Pharmacopeia (USP) and the European Pharmacopoeia (Ph. Eur.), is mandatory. These standards specify the acceptable levels of impurities, microbial limits, and the required physical and chemical properties. Manufacturers must also adhere to Good Manufacturing Practices (GMP), which encompass quality management systems, hygiene standards, and documentation procedures. The adherence to these stringent regulations ensures that pharmaceutical grade sodium chloride is safe for use in medical applications and meets the highest quality Scope Report Features: Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030. In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Company Profiles: Coverage of players such as Akzo Nobel NV, Dominion Salt Ltd., Hebei Huachen Pharmaceutical Co., Ltd., K+S France S.A.S., Morton Salt, Inc. and more. Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments. Key Insights: Market Growth: Understand the significant growth trajectory of the Dialysis segment, which is expected to reach US$417.5 Million by 2030 with a CAGR of a 6.0%. The Injections segment is also set to grow at 6.3% CAGR over the analysis period. Regional Analysis: Gain insights into the U.S. market, valued at $192.0 Million in 2024, and China, forecasted to grow at an impressive 5.2% CAGR to reach $151.5 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific. Tariff Impact Analysis: Key Insights for 2025What's Included in This Edition: Tariff-adjusted market forecasts by region and segment Analysis of cost and supply chain implications by sourcing and trade exposure Strategic insights into geographic shifts Buyers receive a free July 2025 update with: Finalized tariff impacts and new trade agreement effects Updated projections reflecting global sourcing and cost shifts Expanded country-specific coverage across the industry Key Attributes: Report Attribute Details No. of Pages 102 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $701.9 Million Forecasted Market Value (USD) by 2030 $973.7 Million Compound Annual Growth Rate 5.6% Regions Covered Global Key Topics Covered: MARKET OVERVIEW Influencer Market Insights Tariff Impact on Global Supply Chain Patterns Pharmaceutical Grade Sodium Chloride - Global Key Competitors Percentage Market Share in 2024 (E) Global Economic Update Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E) MARKET TRENDS & DRIVERS Increasing Demand for Injectable Drugs Drives Market Growth Rising Use of Sodium Chloride in Dialysis Solutions Expands Market Opportunity Growth in IV Fluid Market Propels Demand for Pharmaceutical Grade Sodium Chloride Advances in Purification Technologies Enhance Product Quality Increasing Investment in Healthcare Infrastructure Development of Biopharmaceuticals and Biosimilars Expansion of Global Pharmaceutical Manufacturing Rising Focus on Drug Formulation and Stability Growth in Clinical Research and Trials Increasing Applications in Oral Rehydration Solutions Advances in Drug Delivery Systems Impacting Sodium Chloride Usage Growth in Emerging Markets Expands Addressable Market Opportunity FOCUS ON SELECT PLAYERS Akzo Nobel NV Dominion Salt Ltd. Hebei Huachen Pharmaceutical Co., Ltd. K+S France S.A.S. Morton Salt, Inc. Salinen Austria Aktiengesellschaft Sudwestdeutsche Salzwerke AG Swiss Saltworks Tianjin Changlu Haijing Group Co., Ltd. US Salt, LLC. For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Pharmaceutical Grade Sodium Chloride Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
35 minutes ago
- Yahoo
North America Web Application Firewall Market Forecast Report 2025-2033, with Key Player Profiles for Akamai Technologies, Cloudflare, Qualys, F5, Fortinet, Radware, Microsoft & Barracuda Networks
As threats evolve, businesses across industries are investing heavily in WAF solutions to protect digital assets, ensure regulatory compliance, and maintain customer trust. Cloud-hosted WAF products offer scalability and easy deployment, spurring adoption. Key sectors include e-commerce, healthcare, and finance. Challenges persist in high implementation costs and integration with legacy systems. North American Web Application Firewall Market Dublin, June 09, 2025 (GLOBE NEWSWIRE) -- The "North America Web Application Firewall Market Size and Growth Trends and Forecast Report 2025-2033" report has been added to North America Web Application Firewall (WAF) Market is expected to expand strongly, increasing from USD 2.13 billion in 2024 to USD 6.65 billion by 2033. The growth is driven by growing cybersecurity threats, an upsurge in web-based applications, and strict data protection laws. Companies across industries are spending big on WAF solutions to protect digital assets, provide regulatory compliance, and preserve customer trust. Growth Drivers in the Web Application Firewall Market in North America Increased Cybersecurity ThreatsIncreased levels and frequency of cyberattacks have hugely driven up the uptake of Web Application Firewalls (WAFs) in North America. Organizations are constantly threatened by ransomware, phishing, and DDoS attacks on their web applications. WAFs offer essential protection by blocking malicious traffic and guarding against data breaches. With an increasing number of businesses migrating more services online, protecting customer data and business data has become more pressing, and WAF adoption across industries has been growing widespread. May 2023, Global cybersecurity software and services company Fortra unveiled an upgraded Managed Web Application Firewall (WAF) service. Offered by Fortra's Alert Logic business, the solution integrates the sophisticated tools and security know-how organizations require to safeguard key web applications and APIs from attack.E-commerce and Digital Services GrowthThe proliferation of online retailing, digital banking, and telemedicine services has driven the demand for solid web application security. As companies expand their online platforms, so too does the attack surface, leaving them increasingly exposed. WAFs secure customer transactions and sensitive data, maintain business continuity and compliance, and support regulatory mandates. The growing need for safe and seamless online experiences is forcing North American businesses to spend generously on sophisticated WAF solutions. Feb 2025, Yottaa, a pioneer in eCommerce website performance optimization, introduced Yottaa Web Performance Services. This managed solution accelerates website performance, increases security, and reduces operational complexity for online retailers and brands. Leverage best-in-class technologies from Fastly, HUMAN Security, and Yottaa, it delivers a high-performance platform optimized for Data Protection RegulationsRegulations such as the California Consumer Privacy Act (CCPA) and vertical regulations such as HIPAA have imposed strict data protection requirements. Firms must protect personal and financial data or incur massive fines. WAFs are important components in compliance initiatives by protecting web applications from unauthorized access and security breaches. The regulatory landscape in North America is driving organizations in various industries - particularly healthcare, finance, and retail - to invest in WAF as a means of evading legal consequences. The California Privacy Rights Act (CPRA), enacted through ballot initiative in November 2020, is the most far-reaching state data privacy law to date. It modifies the California Consumer Privacy Act (CCPA) and became effective in January in the North America Web Application Firewall Market High Implementation and Maintenance CostsIt is costly to implement and manage WAF solutions, particularly in small and medium-sized enterprises (SMBs). The costs consist of software licenses, hardware appliances, professional IT personnel, and maintenance. Such costs might drive most organizations away from investing in high-quality WAF systems, especially when matching limited cybersecurity budgets. Moreover, regular updates and tuning must be done to ensure that WAFs remain effective, and this contributes to the overall cost of ownership and represents a serious market Integration with Legacy SystemsMost North American businesses have legacy IT infrastructure. It is complex and expensive to integrate newer WAF solutions with older systems. Integration can lead to compatibility problems, poor system performance, and rising operation risks. The complexity tends to hinder or slow down WAF deployment, particularly in traditional sectors such as manufacturing and government, and thus brakes the overall expansion of the WAF market across North States Web Application Firewall MarketThe United States leads the North America WAF market due to a widespread presence of healthcare organizations, financial institutions, and tech giants. High WAF adoption rates are being driven by stringent regulatory standards, increasing cybersecurity threats, and operational resilience demands. U.S. firms are making investments in both cloud and on-premises WAF products to protect their assets from sophisticated threats and also remain compliant with federal and state data protection legislation. March 2025, Akamai Technologies, Inc. has been identified as a Leader in The Forrester Wave: Web Application Firewall Solutions, Q1 2025 Web Application Firewall MarketCanada's WAF market is steadily developing, with momentum provided by measures to strengthen country-level cybersecurity capabilities and defend sensitive infrastructure. Enterprise adoption of digital services in Canada is growing fast, which ranks cybersecurity high as a concern. Banking, health, and the government are industries that lead in WAF consumption. Beyond defenses against data intrusions, Canada's WAFs enable entities to comply with privacy regulations such as PIPEDA. June 2024: Vercara is opening its first distributed denial-of-service (DDoS) and application security (AppSec) point of presence (PoP) in Toronto, Canada. The new PoP expands Vercara's international presence for its UltraDDoS Protect and UltraWAF solutions, providing Canadian customers with an in-country data processing and mitigation Web Application Firewall MarketMexico's WAF market is growing as companies go digital and face an increasing number of cyber attacks. Sectors like finance, retail, and manufacturing are prioritizing web application security to safeguard consumer information and business processes. While awareness of cybersecurity has increased, market issues persist in terms of cost and technical skills. Nevertheless, growing investments in IT security and government initiatives are driving WAF adoption in the country. Key Players Analysis Akamai Technologies, Inc. Cloudflare Inc. Qualys Inc. F5 Inc. Fortinet Inc. Radware Ltd. Microsoft Corporation Barracuda Networks, Inc. Key Attributes: Report Attribute Details No. of Pages 200 Forecast Period 2024 - 2033 Estimated Market Value (USD) in 2024 $2.13 Billion Forecasted Market Value (USD) by 2033 $6.65 Billion Compound Annual Growth Rate 13.5% Regions Covered North America North America Web Application Firewall Market Segmentation Component Solution Services Organization Type Large Enterprises Small and Medium Enterprises Deployment Mode On-Premise Cloud Industry Vertical Retail BFSI Manufacturing Government IT & Telecommunication Healthcare Energy & Utilities Others Countries United States Canada Mexico Rest of North America The key players have been analyzed by: Overviews Key Persons Recent Developments Revenue For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment North American Web Application Firewall Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Business Wire
42 minutes ago
- Business Wire
CGT Global Supports Renown Health in Advancing Breast Cancer Treatment in Nevada
RENO, Nev.--(BUSINESS WIRE)--CGT Global, a leader in cell and gene therapy access, is proud to announce their support for the Conrad Breast Center at Renown South Meadows Medical Center in Reno, Nevada. As part of CGT's contribution, the Center's Pharmacy Office will carry the 'CGT Global' name. The financial contribution, made on behalf of CGT Global, our clients, and industry partners, reflects our mission to expand access to life-changing treatments. We are honored to support Renown Health's vision and help bring next-generation care to Nevada. 'Our support for Renown Health reflects CGT Global's broader vision to bring cutting-edge therapies from the lab bench to the bedside,' said Cate Spears, CEO & Founder of CGT Global. 'We believe scientific breakthroughs must translate into real-world impact. We love that the new breast cancer center will provide more fully integrated and multidisciplinary access to treatment across the region.' The Conrad Breast Center will offer comprehensive services such as imaging, counseling for patients with increased risk for developing cancer , breast surgical oncology, medical oncology, radiation oncology, infusion therapy, evidence-based wellness medicine, and clinical research. The Center opened last week, and promises world-class, patient-centered care. Renown Health's Pennington Cancer Institute has been recognized among the top 100 cancer programs in the US by Becker's Hospital Review. CGT Global will continue to support organizations with a shared commitment to delivering cutting-edge therapies to local communities. Our support reflects our ongoing mission to enable emerging treatments like cell and gene therapy—powerful tools in the long-term fight against cancer. We believe that strong partnerships will help lead a new era of personalized medicine—grounded in science, community, and care. About CGT Global CGT Global is a biotechnology company advancing access to cell and gene therapies. With a national network of clinical sites and laboratories, CGT Global delivers high-quality biospecimens, GMP-compliant manufacturing, and end-to-end support to accelerate therapeutic development. Headquartered in Folsom, CA, CGT Global partners with top pharmaceutical companies, CROs, and hospitals. Learn more at
